• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

HDI 3000 drives ATL revenue numbers

Article

Ultrasound vendor ATL continues to enjoy strong momentum fromsales of its premium HDI 3000 scanner. The Bothell, WA, companythis month reported year-end financial results that show worldwiderevenues up 9%. For 1995, ATL had revenues of $399.4 million

Ultrasound vendor ATL continues to enjoy strong momentum fromsales of its premium HDI 3000 scanner. The Bothell, WA, companythis month reported year-end financial results that show worldwiderevenues up 9%.

For 1995, ATL had revenues of $399.4 million compared withsales of $366.2 million in 1994. Net income improved sharply,to a net profit of $12 million in 1995 from a net loss of $20.2million in 1994, when ATL took charges relating to its consolidationof Interspec and litigation with SRI International. In 1995, ATLalso enjoyed a one-time benefit of $6.5 million related to a favorablestate sales tax audit and its new joint venture with Hitachi (SCAN11/22/95).

ATL's fourth-quarter numbers show that its momentum increasedas the year drew to a close. Fourth-quarter revenues rose 14%to $119.1 million, compared with $104.7 million in the same periodof 1994. Net income was $12.2 million compared with a net lossof $5.8 million in the fourth quarter of 1994. The Hitachi investmentof $6.2 million was recorded in the fourth quarter of 1995.

The company's growth was due to market acceptance of HDI 3000,as well as strong sales of ATL's mid-range Apogee product linein international markets, according to chairman and CEO DennisFill. ATL this month announced that as of the end of 1995 it hadshipped over 1000 HDI 3000 scanners. The company also said thatit was named as a preferred vendor for radiology ultrasound byUniversity HealthSystem Consortium of Oak Brook, IL.

Recent Videos
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.